display

The FDP rejects the bill for an amendment to the Infection Protection Act.

"The draft in the current version is not approvable for the Free Democrats", wrote FDP parliamentary group leader Christian Lindner in a letter to Chancellor Angela Merkel (CDU) and Health Minister Jens Spahn (CDU), which WELT is available.

"In contrast to the federal government, we have doubts as to whether this legislative project does not require the approval of the Federal Council after all." Lindner announced amendments.

The introduction of a night curfew with a seven-day incidence of 100 is "a disproportionate and epidemiologically unfounded interference with the freedom of citizens," writes Lindner.

He pointed out that several courts have already lifted curfews and studies have shown the measure to be poorly effective.

The draft also lacks a legal clarification with regard to vaccinated persons in the Infection Protection Act, warned Lindner.

In addition, Lindner called the seven-day incidence unsuitable as the sole benchmark for protective measures.

The 100 incidence is "a politically determined and not an epidemiologically justified threshold".

The assessment of the epidemic situation should therefore also include other key figures, such as the inclusion of test capacities and the proportion of positive results, the burden on the health system and the progress of vaccination.

display

Saxony's Prime Minister Michael Kretschmer (CDU) also called for the incidence value to be supplemented with a key figure for the utilization of intensive care beds.

According to Kretschmer, curfews should only be necessary from an incidence of 200.

Compared to WELT, Kretschmer announced "considerable need for discussion" on the planned Infection Protection Act.

display

Buy antigen self-tests online now

Take a nasal swab, read the result on the test strip within 15 minutes and find out whether you have Covid-19.

Order 1 item from Amazon Order 5 items from Galeria Kaufhof Order 10 items from APONEO Order 25 items from APONEO

All developments in the live ticker